A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)

18 participants · First posted Apr 17, 2026

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

32 participants · First posted Jan 30, 2014

Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer

10 participants · First posted Dec 8, 2023

Autologous T cells therapy(Unicar-Therapy)

CBR/CMR therapy(Hemogenyx)

Anti-EPCAM CAR-T cell therapy (Sinobioway)

METABOLIC THERAPY, INC.

United States

Everads Therapy Ltd.

Israel

ATI Physical Therapy

United States

Novel VMS Therapy Shows Early Promise in Improving Quality of Life for Breast Cancer Patients

FDA Accepts Bayer's Elinzanetant for Review in Menopausal Vasomotor Symptoms

Astellas' Fezolinetant Enters Phase 3 Trial for VMS in Breast Cancer Patients on Endocrine Therapy